10 results found

On August, 5, 2016, Argentineans were warned about adulterated products for washing clothes by the Argentinean National Administration of Medicines, Food and Medical Technology (ANMAT).

On January 13th, 2017, the Official Gazette of Buenos Aires City published Law No. 5709, which aims to provide patients a tool that allows them to have as much information as possible about conflicts...

In May 2016, FDA sent the second warning letter to the Argentinian manufacturing medical device company.

Laboratories and other healthcare industry companies granting payments and benefits to physicians may face different liabilities under Argentine Law, calling for a cautious...

Employers in Argentina should look closely at cost increases resulting from sweeping reforms that allow healthcare providers to adjust plans' premiums on their own terms.

Argentina has introduced tighter restrictions on travellers entering the country, limiting entry to a very narrow list of individuals and imposing strict testing and quarantine restrictions on most...

Through the enactment of Law No. 5709, the City of Buenos Aires has taken a step forward regarding patient protection and possible conflicts of interest that might affect therapeutic decisions...